CGMP Flashcards
Many industries are faced with a common phenomenon forcing them to ____________ ________________ in the face of challenges
Reinvent themselves
Only companies that are willing to change or modify their strategies followed by _______________ _______________ will have ___________________
Excellent execution
Long-term success
Due to increased SCRUTINY and HIGHER SAFETY STANDARDS
- Decline in the number of new chemical entities (NCEs)
At the end of patents, generic drug makes UNDERCUT the profit margin
Increased Generic Competition
Driven by the need to improve the regulatory process to meet CURRENT EXPECTATIONS
Regulatory changes
Done to demonstrate the VALUE they bring to patients and stakeholders
Regulatory changes
Common problems faced by pharmaceutical companies
- Decline in the number of new chemical entities
- Increased Generic Competition
- Regulatory changes
Potential significant sources of economic, developmental and drug market growth
E7 countries or non industrialized countries China India Brazil Russia Turkey South Korea Poland
Having significant business activities OTHER THAN the traditional pharmaceutical arena
Diversification
Integrate _________ in all aspects of drug manufacture
Quality
Good pharmaceutical quality represents ____________________ to achieve the desired ________________ for the sake of patients
Low risk of failing
Clinical attributes
It is the TOTAL of the features and characteristics of a product to SATISFY a given need
Quality before
Quality before is
Conformance to requirements and specifications
Fitness of purpose
Focus of quality before
Compliance-centered
Quality now is a predictable degree of
Uniformity
Dependability
Low cost
Suitability
Focus of quality now
Patient-centered
PLANNED SYSTEM of activities to ensure effective quality control
Quality assurance
It involves ALL aspects of manufacturing
Quality assurance